{
    "eid": "2-s2.0-85115788844",
    "title": "A systematic review of proton therapy for the management of nasopharyngeal cancer",
    "cover-date": "2021-06-01",
    "subject-areas": [
        {
            "@_fa": "true",
            "$": "Atomic and Molecular Physics, and Optics",
            "@code": "3107",
            "@abbrev": "PHYS"
        },
        {
            "@_fa": "true",
            "$": "Radiology, Nuclear Medicine and Imaging",
            "@code": "2741",
            "@abbrev": "MEDI"
        }
    ],
    "keywords": [
        "Nasopharyngeal cancer",
        "Proton therapy",
        "Systematic review"
    ],
    "authors": [
        "Anna Lee",
        "Sarin Kitpanit",
        "Marina Chilov",
        "Johannes A. Langendijk",
        "Jiade Lu",
        "Nancy Y. Lee"
    ],
    "citedby-count": 6,
    "ref-count": 36,
    "ref-list": [
        "Cancer incidence and mortality worldwide: Sources, methods and major patterns in GLOBOCAN 2012",
        "Intensity-modulated radiation therapy with or without chemotherapy for nasopharyngeal carcinoma: Radiation therapy oncology group phase II trial 0225",
        "Addition of bevacizumab to standard chemoradiation for locoregionally advanced nasopharyngeal carcinoma (RTOG 0615): A phase 2 multi-institutional trial",
        "Treatment outcomes after reduction of the target volume of intensity-modulated radiotherapy following induction chemotherapy in patients with locoregionally advanced nasopharyngeal carcinoma: A prospective, multi-center, randomized clinical trial",
        "Quality of life in patients cured from a carcinoma of the head and neck by radiotherapy: The importance of the target volume",
        "Health-related quality of life for nasopharyngeal carcinoma patients with cancer-free survival after treatment",
        "Assessment of quality of life of nasopharyngeal carcinoma patients with EORTC QLQ-C30 and H&N-35 modules",
        "A cross sectional study in cognitive and neurobehavioral impairment in long-term nasopharyngeal cancer survivors treated with intensity-modulated radiotherapy",
        "Long-term disease-specific and cognitive quality of life after intensity-modulated radiation therapy: A cross-sectional survey of nasopharyngeal carcinoma survivors",
        "Beam path toxicities to non-target structures during intensity-modulated radiation therapy for head and neck cancer",
        "The potential benefit of radiotherapy with protons in head and neck cancer with respect to normal tissue sparing: A systematic review of literature",
        "Multifield optimization intensity modulated proton therapy for head and neck tumors: A translation to practice",
        "Intensitymodulated radiotherapy of nasopharyngeal carcinoma: A comparative treatment planning study of photons and protons",
        "Intensity-modulated proton therapy versus helical tomotherapy in nasopharynx cancer: Planning comparison and NTCP evaluation",
        "Preferred reporting items for systematic reviews and metaanalyses: The PRISMA statement",
        "Acute toxicity in comprehensive head and neck radiation for nasopharynx and paranasal sinus cancers: Cohort comparison of 3D conformal proton therapy and intensity modulated radiation therapy",
        "Proton therapy reduces treatment-related toxicities for patients with nasopharyngeal cancer: A case-match control study of intensity-modulated proton therapy and intensity-modulated photon therapy",
        "Intensity-modulated proton therapy for nasopharyngeal carcinoma: Decreased radiation dose to normal structures and encouraging clinical outcomes",
        "Efficacy and toxicity of proton with photon radiation for locally advanced nasopharyngeal carcinoma",
        "Clinical results of proton therapy reirradiation for recurrent nasopharyngeal carcinoma",
        "Early clinical outcomes of helical tomotherapy/intensity-modulated proton therapy combination in nasopharynx cancer",
        "Individualization of clinical target volume delineation based on stepwise spread of nasopharyngeal carcinoma: Outcome of more than a decade of clinical experience",
        "Mixed-beam approach in locally advanced nasopharyngeal carcinoma: IMRT followed by proton therapy boost versus IMRT-only: Evaluation of toxicity and efficacy",
        "Proton pencil-beam scanning radiotherapy in the treatment of nasopharyngeal cancer: Dosimetric parameters and 2-year results",
        "Identification of patient benefit from proton therapy for advanced head and neck cancer patients based on individual and subgroup normal tissue complication probability analysis",
        "Concurrent chemotherapy for T4 classification nasopharyngeal carcinoma in the era of intensity-modulated radiotherapy",
        "A randomized phase II/III study of adverse events between sequential (SEQ) versus simultaneous integrated boost (SIB) intensity modulated radiation therapy (IMRT) in nasopharyngeal carcinoma; Preliminary result on acute adverse events",
        "Physics controversies in proton therapy",
        "Intensity-modulated radiation therapy (IMRT) for nasopharynx cancer: Update of the Memorial Sloan-Kettering experience",
        "Ten-year survival outcomes for patients with nasopharyngeal carcinoma receiving intensity-modulated radiotherapy: An analysis of 614 patients from a single center",
        "Analysis of dosimetric factors associated with temporal lobe necrosis (TLN) in patients with nasopharyngeal carcinoma (NPC) after intensity modulated radiotherapy",
        "Prognostic variables for temporal lobe injury after intensity modulatedradiotherapy of nasopharyngeal carcinoma",
        "Temporal lobe necrosis in head and neck cancer patients after proton therapy to the skull base",
        "Proton versus photon radiotherapy for nasopharyngeal carcinoma",
        "Proton radiotherapy with chemotherapy for nasopharyngeal carcinoma",
        "Individualized treatment in treating patients with stage II-IVB nasopharyngeal cancer based on EBV DNA"
    ],
    "affiliation": [
        {
            "affiliation-city": "New York",
            "@id": "60009343",
            "affilname": "Memorial Sloan-Kettering Cancer Center",
            "@href": "https://api.elsevier.com/content/affiliation/affiliation_id/60009343",
            "affiliation-country": "United States"
        },
        {
            "affiliation-city": "Shanghai",
            "@id": "60108904",
            "affilname": "Fudan University Shanghai Cancer Center",
            "@href": "https://api.elsevier.com/content/affiliation/affiliation_id/60108904",
            "affiliation-country": "China"
        },
        {
            "affiliation-city": "Bangkok",
            "@id": "60028190",
            "affilname": "Chulalongkorn University",
            "@href": "https://api.elsevier.com/content/affiliation/affiliation_id/60028190",
            "affiliation-country": "Thailand"
        },
        {
            "affiliation-city": "Houston",
            "@id": "60015023",
            "affilname": "The University of Texas MD Anderson Cancer Center",
            "@href": "https://api.elsevier.com/content/affiliation/affiliation_id/60015023",
            "affiliation-country": "United States"
        },
        {
            "affiliation-city": "Groningen",
            "@id": "60006027",
            "affilname": "Universitair Medisch Centrum Groningen",
            "@href": "https://api.elsevier.com/content/affiliation/affiliation_id/60006027",
            "affiliation-country": "Netherlands"
        }
    ],
    "funding": [
        "National Institutes of Health",
        "National Institute of Biomedical Imaging and Bioengineering",
        "Pfizer",
        "Astra Zeneca",
        "Merck",
        "Siemens"
    ]
}